Role of pelvic lymphadenectomy in the management of Stage I endometrial cancer: our experience

Objectives: To estimate the prognostic value of pelvic-node removal on survival of patients affected by endometrial carcinoma at presurgical FIGO Stage I.

Methods: A retrospective analysis was performed on a total of 111 patients recruited from 1990 to 1996 at the S. Carlo di Nancy Hospital. Thirty-nine (35%) of them underwent a total hysterectomy and bilateral salpingo-oophorectomy with removal of the vaginal cuff (group 1), while 72 (65%) underwent a total hysterectomy combined with pelvic lymphadenectomy (group 2). Prognostic features including tumor grade, depth of myometrial invasion and histologic subtype. Survival rates were calculated with Cox and Kaplan analyses.

Results: Overall survival rate at five years was 91.2%. The survival rate of group 1 and group 2 was 89% and 92.8%, respectively which is not statistically significant. Stage, grade, histotype, age at diagnosis, and presence of positive lymph nodes did not show any significant prognostic value on survival probability.

Conclusions: The survival rate for patients submitted to lymphadenectomy (group 2) was the same of patients who did not undergo this treatment (group 1). Nevertheless, pelvic lymphadenectomy in endometrial carcinoma at presurgical FIGO stage I was worthwhile as it allowed correct staging to be performed. The prediction of nodal disease based only on preoperative investigations (such as TC, NMR) is often inaccurate.

Endometrial cancer; Lymphadenectomy; Staging; Total abdominal hysterectomy

[1] Morrow C. P., Bundy B. N., Kurman R. J. et al.: "Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study". Gynecol. Oneal., 1991, 40 (1), 55.

[2] Di Saia P. J., Creasman W. T., Boronow R. C., Blessing J. A.: "Risk factors and recurrence patterns in stage I endometrial cancer". Am. J. Obstet. Gynecol., 1985, 151, 1009.

[3] Homesley H. D., Kadar N., Barrett R. J. et al.: "Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma". Am. J. Obstet Gynecol., 1992, 167 (5), 1225.

[4] Piver M., Rutledge F., Smith J.: "Five classes of extended hysterectomy for women with cervical cancer". Obstet. Gynaecol., 1974, 44, 265.

[5] The LINCE study group (Italy): "Feasibilily and complications of systematic lymphadenectomy in endometrial cancer. Preliminary results of a prospective randomized multicentric clinical trial". Int. J. Gynecol. Cancer, 1999, 9,（suppl. I), 4.

[6] Kilgore L. C., Partridge E. E., Alvarez R. D. et al.: "Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling". Gynecol. Oncol., 1995, 56, 29.

[7] Orr J. W.: "Surgical staging of endometrial cancer: does the patient benefit?". Gynecol. Oneal., (editorial), 1998, 71, 335.

[8] Mohan D. S., Samuels M.A., Selim M.A. et al.: "Long- term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial carcinoma". Gynecol. Oneal., 1998, 70, 165.

[9] Orr J. W., Holimon J. L., Orr P. F.: "Stage I corpus cancer: is teletherapy necessary?". Am. J. Obstet. Gynecol., 1997, 176, 777.

[10] Partridge E. E.: "Endometrial cancer, changing concepts in therapy". Surg. Clin. North Am., 1991, 71, 991.

[11] Wolfson A.H., Slightier S. E., Markoe A. M. et al.: "The prognostic significance of surgical staging for carcinoma of the endometriu". Gynecol. Oneal., 1992, 45, 142.

[12] COSA-NZ-UK: "Endometrial Cancer Study Groups: Pelvic lymphadenectomy in high risk endometrial cancer". Int. J. Gynecol. Cancer, 1996, 6, 102.

[13] Bar-Am A., Ron I. G., Kupermink M. et al.: "The role of routine pelvic lymphnode sampling in patients with stage I endometrial carcinoma: second thoughts". Acta Obstet. Gynecol. Scand., 1998, 77, 347.

[14] Trimble E. L., Kosary C., Park R. C.: "Lymph node sampling and survival in endometrial cancer". Gynecol. Oneal., 1998, 71, 340.